Molecular Design, Synthesis, and Evaluation of SNIPER(ER) That Induces Proteasomal Degradation of ERα. (Q52901738)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Molecular Design, Synthesis, and Evaluation of SNIPER(ER) That Induces Proteasomal Degradation of ERα (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Norihito Shibata

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

4

Nobumichi Ohoka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

3

Takayuki Hattori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

7

Mikihiko Naito

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Keiichiro Okuhira

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Masaaki Kurihara

series ordinal

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

English

0 references

publication date

1 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

Methods in Molecular Biology

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

1366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

549-560

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

Specific degradation of CRABP-II via cIAP1-mediated ubiquitylation induced by hybrid molecules that crosslink cIAP1 and the target protein.

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-binding proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Development of target protein-selective degradation inducer for protein knockdown.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Design, synthesis and biological evaluation of nuclear receptor-degradation inducers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Final overall survival: fulvestrant 500 mg vs 250 mg in the randomized CONFIRM trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

A convenient synthesis of (Z)-4-hydroxy-N-desmethyltamoxifen (endoxifen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

Measurement of protein using bicinchoninic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2F978-1-4939-3127-9_42

10.1007/978-1-4939-3127-9_42

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26585163%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference